Skip to content

Study of Tissue Expansion Devices Complications

Intervention Study of Common Complications About Patients Placed Tissue Expansion Devices

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03084887
Acronym
STEDC
Enrollment
208
Registered
2017-03-21
Start date
2016-11-10
Completion date
2018-02-28
Last updated
2017-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tissue Expansion

Keywords

Tissue Expansion Devices, Tissue Expansion, common complications, intervention study

Brief summary

Reduce the common complications incidence about patients placed tissue expansion devices to around 5%.

Detailed description

Study design: Randomized parallel controlled trial. Study comments: 1.Telephone follow-up trainment group about 2-3 months until secondary hospital. 2.Promote the health management manual of patient placed expander,which includes discharge list, injection list, expander affusion operation procedure, injection myth, you ask me answer,injection record, injection diary record, appointment diaries etc.

Interventions

BEHAVIORALmanuals and follow-up

distribute manuals for patients before discharge and telephone follow-up per week until secondary hospital

Sponsors

First Affiliated Hospital Xi'an Jiaotong University
CollaboratorOTHER
Xijing Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* aged 1-70 years male and female; * no complication when inclusion; * sign the informed consent.

Exclusion criteria

* joined other clinical trial; * occurred complications before inclusion; * other infectious diseases; * the pregnant or lactating women.

Design outcomes

Primary

MeasureTime frameDescription
incidence of patients suffered the common complications2-3 months until secondary hospitalcount up the number of patients suffered the common complications

Countries

China

Contacts

Primary ContactXiaoling Wang, master
wxl_20070925@126.com+86 18009290090
Backup Contactyanyan Jia, master
jiayanyan-2004@hotmail.com+86 02984771794

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026